Insider · CIK 0001642355

Braslyn Ltd.

Reports to the SEC for 6 companies · NEW PROVIDENCE, C5

sec.gov

Transactions

Companies

Filings

CIK

0001642355

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-03-10	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−20 sh	$196.12	−$3,922.4	3,135,757
2021-03-10	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−189 sh	$195.52	−$37K	3,135,777
2021-03-10	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1 sh	$195.90	−$195.9	3,135,966
2021-03-10	Mirati Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+410 sh	$0.00	+$0.41	3,135,967
2021-03-10	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−200 sh	$198.00	−$39.6K	3,135,557
2021-03-09	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1 sh	$191.00	−$191	3,135,966
2021-03-09	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1,107 sh	$195.82	−$217K	3,134,859
2021-03-09	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−4,633 sh	$197.30	−$914K	3,130,226
2021-03-09	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−3,993 sh	$197.81	−$790K	3,126,233
2021-03-09	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−2,237 sh	$199.08	−$445K	3,123,996
2021-03-09	Mirati Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+12K sh	$0.00	+$11.971	3,135,967
2020-12-16	INSGINSEEGO CORP.S Sale	10% Owner	SSale	−294K sh	$14.37	−$4.22M	7,614,830
2020-12-15	INSGINSEEGO CORP.S Sale	10% Owner	SSale	−191K sh	$14.81	−$2.82M	7,908,678
2020-12-14	INSGINSEEGO CORP.S Sale	10% Owner	SSale	−179K sh	$16.07	−$2.88M	8,099,268
2020-12-14	INSGINSEEGO CORP.S Sale	10% Owner	SSale	−1.72M sh	$15.62	−$26.9M	8,278,217
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−10.6K sh	$210.58	−$2.23M	3,105,078
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−3,108 sh	$212.66	−$661K	3,087,562
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−2,344 sh	$214.31	−$502K	3,085,218
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−28K sh	$215.08	−$6.02M	3,057,226
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−11.7K sh	$216.06	−$2.52M	3,045,570
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−6,775 sh	$217.14	−$1.47M	3,038,795
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−5,912 sh	$218.04	−$1.29M	3,032,883
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−663 sh	$218.85	−$145K	3,032,220
2020-10-29	Mirati Therapeutics, Inc.F Tax Payment	See remarks	FTax Payment	−1 sh	$202.25	−$202.25	3,135,966
2020-10-29	Mirati Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+105K sh	$0.00	+$104.565	3,135,967
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−818 sh	$220.02	−$180K	3,031,402
2020-10-29	Mirati Therapeutics, Inc.Warrant (right to purchase)M Exercise/Conversion	See remarks	MExercise/Conversion	−105K sh	$5.60	−$585K	3,590,421
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−550 sh	$203.32	−$112K	3,135,416
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−800 sh	$205.64	−$165K	3,134,616
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1,088 sh	$206.50	−$225K	3,133,528
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1,086 sh	$207.96	−$226K	3,132,442
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−1,674 sh	$208.78	−$349K	3,130,768
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−15.1K sh	$209.66	−$3.16M	3,115,677
2020-10-29	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−14.4K sh	$211.50	−$3.05M	3,090,670
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−37.4K sh	$209.47	−$7.84M	2,864,313
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−23.3K sh	$210.31	−$4.9M	2,841,030
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−500 sh	$211.06	−$106K	2,840,530
2020-10-28	Mirati Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+295K sh	$0.00	+$295.438	3,135,968
2020-10-28	Mirati Therapeutics, Inc.F Tax Payment	See remarks	FTax Payment	−2 sh	$209.16	−$418.32	3,135,966
2020-10-28	Mirati Therapeutics, Inc.Warrant (right to purchase)M Exercise/Conversion	See remarks	MExercise/Conversion	−295K sh	$5.60	−$1.65M	3,694,986
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−45K sh	$203.35	−$9.14M	3,091,007
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−38.5K sh	$204.57	−$7.88M	3,052,464
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−45.9K sh	$205.49	−$9.43M	3,006,568
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−41.3K sh	$206.50	−$8.52M	2,965,302
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−38.5K sh	$207.35	−$7.99M	2,926,777
2020-10-28	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−25K sh	$208.40	−$5.22M	2,901,741
2020-06-12	Mirati Therapeutics, Inc.S Sale	See remarks	SSale	−600K sh	$69.00	−$41.4M	2,535,966
2020-06-12	Mirati Therapeutics, Inc.M Exercise/Conversion	See remarks	MExercise/Conversion	+600K sh	$0.00	+$600.006	3,135,972
2020-06-12	Mirati Therapeutics, Inc.F Tax Payment	See remarks	FTax Payment	−6 sh	$72.80	−$436.8	3,135,966
2020-06-12	Mirati Therapeutics, Inc.Warrant (right to purchase)M Exercise/Conversion	See remarks	MExercise/Conversion	−600K sh	$5.60	−$3.36M	3,990,420

Recent filings

Accepted (ET)
Mar 104
LEWIS JOSEPH0000899243-21-011086
SEC(opens sec.gov)
Dec 164
Braslyn Ltd.0000899243-20-034137
SEC(opens sec.gov)
Oct 304
Braslyn Ltd.0000899243-20-030059
SEC(opens sec.gov)

Companies

Address

C/O CAY HOUSE, P.O. BOX N-7776 E.P. TAYLOR DRIVE LYFORD CAY

NEW PROVIDENCE, C5